Advicenne S.A. (FRA:3MM)
Germany · Delayed Price · Currency is EUR 1.746
+0.012 (0.69%)
At close: Nov 28, 2025
Advicenne Company Description
Advicenne S.A., a specialty pharmaceutical company, develops, commercializes, and markets treatments for rare renal diseases in France and internationally.
The company offers Sibnayal for the treatment of metabolic disorders, distal renal tubular acidosis, and cystinuria.
It also distributes Likozam, a formulation of clobazam for the treatment of short-term symptomatic of severe, disabling, or condition-causing anxiety unacceptable distress; and Levidcen, a galenic form of levetiracetam for the treatment of epileptic seizures.
Advicenne S.A. was incorporated in 2007 and is headquartered in Paris, France.
Advicenne S.A.
| Country | France |
| Founded | 2007 |
| Industry | Pharmaceutical Preparations |
| Employees | 13 |
| CEO | Didier Laurens |
Contact Details
Address: 3Eme Etage Paris, 75008 France | |
| Phone | 33 1 85 73 36 20 |
| Website | advicenne.com |
Stock Details
| Ticker Symbol | 3MM |
| Exchange | Frankfurt Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Didier Laurens | Chief Executive Officer |
| Isabelle Kervella | Chief Financial Officer |